Louisa Hempel Constantin Lapa Alexander Dierks Andreas Gaumann Josef Scheiber Julia Veloso de Oliveira Patrick Philipp Cristina Oyarzun Laura Stefan Wesarg Sebastian Robert Dirk Hempel
10.1177/17588359221125096
Ther Adv Med Oncol
2022 Sep 26;14:17588359221125096.
fgfr2 cholangiocarcinoma mixed-all-nominated-in-one method next-generation sequencing targeted therapy tyrosine kinase inhibitor
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/36188486/
Case Reports
PMC9520138
36188486
A new promising oncogenic target (p.C382R) for treatment with pemigatinib in patients with cholangiocarcinoma
2022